5-[[5-fluoro-4-[4-(pyridin-4-ylmethyl)anilino]pyrimidin-2-yl]amino]-2-methoxybenzenesulfonamide
C23H21FN6O3S — CID 68871275
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[5-fluoro-4-[4-(pyridin-4-ylmethyl)anilino]pyrimidin-2-yl]amino]-2-methoxybenzenesulfonamide
5-[[5-fluoro-4-[4-(pyridin-4-ylmethyl)anilino]pyrimidin-2-yl]amino]-2-methoxybenzenesulfonamide (PubChem CID 68871275) has the molecular formula C23H21FN6O3S and a molecular weight of 480.53 g/mol. Its IUPAC name is 5-[[5-fluoro-4-[4-(pyridin-4-ylmethyl)anilino]pyrimidin-2-yl]amino]-2-methoxybenzenesulfonamide.
Molecular Properties
| Compound Name | 5-[[5-fluoro-4-[4-(pyridin-4-ylmethyl)anilino]pyrimidin-2-yl]amino]-2-methoxybenzenesulfonamide |
|---|---|
| PubChem CID | 68871275 |
| Molecular Formula | C23H21FN6O3S |
| Molecular Weight | 480.53 g/mol |
| Exact Mass | 480.14 |
| IUPAC Name | 5-[[5-fluoro-4-[4-(pyridin-4-ylmethyl)anilino]pyrimidin-2-yl]amino]-2-methoxybenzenesulfonamide |
| SMILES | COc1ccc(Nc2ncc(F)c(Nc3ccc(Cc4ccncc4)cc3)n2)cc1S(N)(=O)=O |
| InChI | InChI=1S/C23H21FN6O3S/c1-33-20-7-6-18(13-21(20)34(25,31)32)29-23-27-14-19(24)22(30-23)28-17-4-2-15(3-5-17)12-16-8-10-26-11-9-16/h2-11,13-14H,12H2,1H3,(H2,25,31,32)(H2,27,28,29,30) |
| InChIKey | UMXSGNRLHBZPLR-UHFFFAOYSA-N |
| XLogP | 3.74 |
| TPSA | 132.12 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.53 |
| LogP ≤ 5 | 3.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 68871275 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.